Cargando…
Thymidine Phosphorylase Is Increased in COVID-19 Patients in an Acuity-Dependent Manner
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is a human respiratory disease. Hitherto, there is no effective treatment has been established. Patients with cardiovascular or diabetes comorbidities are a high-risk cohort. COVID-19 is...
Autores principales: | Li, Wei, Yue, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019714/ https://www.ncbi.nlm.nih.gov/pubmed/33829029 http://dx.doi.org/10.3389/fmed.2021.653773 |
Ejemplares similares
-
The cytosol activity of thymidine phosphorylase in endometrial cancer
por: Miszczak-Zaborska, Elżbieta, et al.
Publicado: (2008) -
Expression of Thymidine Phosphorylase in Human Gastric Carcinoma
por: Takebayashi, Yuji, et al.
Publicado: (1996) -
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel
por: Bartsch, Rupert, et al.
Publicado: (2007) -
Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
por: Hata, K, et al.
Publicado: (1999) -
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
por: Di Gennaro, E, et al.
Publicado: (2010)